Mepsgen

Developer of human organ model chips for pharmaceutical development

placeSeoul, Seoul, South Korea calendar_todayFounded 2019 groups20 employees language mepsgen.com

Innovation

14 patent families (7 granted) — focus: Human necessities, Chemistry & metallurgy, Operations & transport; filing pace accelerating. Cited 299 times.

YearFilings
20211
20222
20234
20249
20259
20266

Social engagement

Social engagement: 1.2K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Yuanda Financial Holdings, KB Investment, E&Investment, Live Cell Instrument.

Investor typeCountShare
Venture capital225%
Private equity113%
Bank & private debt225%
Other / undisclosed338%

Recent activity

25 Jun 2026
Event
BIO International Convention 2026
17 Jun 2026
Event
BIO International Convention 2026
15 Jun 2026
Event
NAMs Industry Mixer
Coming soon